NH Business Review NH companies attract investment and recognition ... and more May 27, 2021 MilliporeSigma’s launches new synthetic cholesterol product, which could be used in mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine. MilliporeSigma has launched a new product nine months ahead of schedule in order to meet what it says is the high demand for lipids, a key component of mRNA-based vaccines and therapeutics. The German manufacturer, which has a location in Jaffrey, NH, is manufacturing the synthetic cholesterol product in Darmstadt, Germany, though it also manufactures lip...